Methods for treating a subject with tyrosinase-positive albinism； agents and compositions thereof for use in treating tyrosinase-positive albinism； and medicaments for treating tyrosinase-positive albinism are described herein. Such methods； agents and compositions thereof； and medicaments relate to chloroquine or rapamycin or compositions thereof and may further relate to nitisinone used in conjunction with the chloroquine or rapamycin or a composition of either of which.
